Ms. Kelly joins the company from CJS Scientific, Ltd., where she served as director and consultant to the pharmaceutical and agrochemical industries in the fields of nonclinical development, toxicology, translational medicine and dossier preparation. Prior to CJS she held several positions at Covance, including director of operations at Covance R&D (Shanghai, China), associate director of business development, head of operations and head of toxicology study direction.
“With more than 26 years of industry experience, Janet has held a number of key posts with progressively responsible roles in study direction, business development and operations,” said Mark Crane, SNBL USA vice president of business development. “Her preclinical market understanding, experiences and direct knowledge of the rapidly changing European market dynamics will be of great value to SNBL USA and all its customers. I am excited to have Janet on our team.”